Keeping you up to date on recent developments in oncology, including: 3D-printed reservoir + magnetic sponge = new way to beat cancer; HRAS-driven translation helps skin prevent tumors; NETS and mets; Observational study supports cryoablation for RCC.
Keeping you up to date on recent developments in oncology, including: Hydrogen peroxide stimulates gold nanorods, paclitaxel, for cancer treatment; Oncometabolites mask DNA repair signals; Stress-induced mutagenesis leads to cancer drug resistance; Nanomotoring in bladder cancer.
Keeping you up to date on recent developments in oncology, including: Hydrogen plus gemcitabine may prove efficacious in treatment of bladder cancer; Tumor types have distinct microbiomes; Kinase helps prepare pre-metastatic niche; EZH2 has dual role; Sulfur-for-oxygen switch enables photosensitizers for cancer therapy.
Keeping you up to date on recent developments in oncology, including: Optoacoustic mesoscopy offers three-dimensional tumor imaging without biopsy; P53 loss leads to immune evasion; Treatment less toxic for Burkitt lymphoma.
Keeping you up to date on recent developments in oncology, including: New LAT1 inhibitor may improve outcomes in cancer as part of combo therapy; Subdividing and conquering PDAC; Cell competition links hyperinsulinemia to cancer; Protons show well in study against alternatives.
Keeping you up to date on recent developments in oncology, including: New nanoparticle proposed as treatment for a ‘wide range of cancers’; CD163-expressing macrophages a sign of poor outcomes; Mevion inks deal for protons in Texas; PSMA PET-CT show well in study of prostate cancer metastasis.
Keeping you up to date on recent developments in oncology, including: Infectious disease diagnoses often foreshadow cancer diagnoses; Polymerase k and drug resistance; Microcytosis link to cancer confirmed; Researchers describe new triple threat to cancer.
Keeping you up to date on recent developments in oncology, including: Targeted Interleukin-12 heats up cold tumors; Therapy allows immune system to ‘manganese’ up against cancer; Proton therapy less toxic than IMRT in new study; Technetium supplies struggling under distribution headaches.
Biofourmis Inc. has acquired Los Angeles-based Gaido Health from Takeda Pharmaceuticals in a move designed to significantly expand the company's oncology offerings. Gaido Health's solution will be integrated into Boston-based Biofourmis' Biovitals platform, enhancing its ability to remotely monitor oncology patients at home using a single sensor.
Keeping you up to date on recent developments in oncology, including: Medical societies ink guidelines for breast cancer care for pandemic; Multiple drivers explained; Study points to new genetic associations for osteosarcoma.
RSS
